Department of Neurosurgery
Almuth F. Kessler has not added Biography.
If you are Almuth F. Kessler and would like to personalize this page please email our Author Liaison for assistance.
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Oct, 2014 | Pubmed ID: 25125481
TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Journal of the National Cancer Institute May, 2016 | Pubmed ID: 26668184
(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Theranostics , 2016 | Pubmed ID: 26909116
Feasibility of the Combined Application of Navigated Probabilistic Fiber Tracking and Navigated Ultrasonography in Brain Tumor Surgery.
World neurosurgery Jun, 2016 | Pubmed ID: 26968447
Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Sep, 2017 | Pubmed ID: 28357650
CXCR4: A new player in vestibular schwannoma pathogenesis.
Oncotarget Feb, 2018 | Pubmed ID: 29515781
O-(2-(F)fluoroethyl)-L-tyrosine PET for the differentiation of tumour recurrence from late pseudoprogression in glioblastoma.
Journal of neurology, neurosurgery, and psychiatry Feb, 2019 | Pubmed ID: 29705720
Prognostic Value of O-(2-[F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.
Molecular imaging and biology Dec, 2019 | Pubmed ID: 30977078
Identification of KIF11 As a Novel Target in Meningioma.
Cancers Apr, 2019 | Pubmed ID: 30991738
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response.
Cancers Jun, 2019 | Pubmed ID: 31200581
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas.
Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2019 | Pubmed ID: 31227506
[Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas.
Frontiers in oncology , 2019 | Pubmed ID: 31245296
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Clinical nuclear medicine Sep, 2019 | Pubmed ID: 31274552
ADAM9: A novel player in vestibular schwannoma pathogenesis.
Oncology letters Mar, 2020 | Pubmed ID: 32194680
Glioma patients in outpatient care-optimization of psychosocial care in neuro-oncological patients (GLIOPT): Protocol for a cluster randomized controlled trial.
Trials May, 2020 | Pubmed ID: 32460811
The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting.
Frontiers in neurology , 2022 | Pubmed ID: 35242096
Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier.
Pharmaceutics Jan, 2023 | Pubmed ID: 36678814
Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
Cancers May, 2023 | Pubmed ID: 37345035
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유